Fig. 2
From: The nasal methylome as a biomarker of asthma and airway inflammation in children
Nasal epigenome-wide associations for fractional exhaled nitric oxide (FeNO), asthma, and allergic asthma. Uncorrected −log10(P values) plotted in the y-axis for each CpG site and sorted by chromosomal and genomic position on the x-axis. Adjustment for multiple testing was accounted for each epigenome-wide association analyses by controlling the false discovery rate (FDR <0.05), horizontal orange dashed line, and Bonferroni threshold for statistical significance (P < 6.95 × 10−8) shown in the solid red horizontal line. a Manhattan plot of epigenome-wide association analyses (EWAS) for fractional exhaled nitric oxide (FeNO), b Manhattan plot of EWAS for current asthma, and c Manhattan plot of EWAS for current allergic asthma
